Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 Per Share
-
Shares outstanding
-
2,139,852
-
Total 13F shares
-
500,210
-
Share change
-
-1,211,661
-
Total reported value
-
$1,305,000
-
Price per share
-
$2.61
-
Number of holders
-
11
-
Value change
-
-$3,186,344
-
Number of buys
-
4
-
Number of sells
-
5
Institutional Holders of Indaptus Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (INDP) as of Q2 2022
As of 30 Jun 2022,
Indaptus Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (INDP) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
500,210 shares.
The largest 10 holders included
VANGUARD GROUP INC, INVESTMENT HOUSE LLC, GEODE CAPITAL MANAGEMENT, LLC, Stratos Wealth Partners, LTD., Vivaldi Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, NORTHERN TRUST CORP, Harel Insurance Investments & Financial Services Ltd., and Tower Research Capital LLC (TRC).
This page lists
11
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.